Results 141 to 150 of about 125,954 (295)

Choroidal neovascularization management in pathological myopia

open access: yes, 2012
New approaches in the diagnosis and therapy of myopic Choroidal neovascularization (CNV). Long-tem effects of anti-VEGF therapy for subfoveal myopic CNV. Best treatment drug: Bevacizumab versus Ranibizumab. Effects of treatment regimen. Effects of myopic CNV location (Juxtafoveal versus Extrafoveal myopic CNV).
openaire   +1 more source

Targeting the Mitochondrial Chaperone TRAP1 Alleviates Vascular Pathologies in Ischemic Retinopathy

open access: yesAdvanced Science
Activation of hypoxia‐inducible factor 1α (HIF1α) contributes to blood‐retinal barrier (BRB) breakdown and pathological neovascularization responsible for vision loss in ischemic retinal diseases.
So‐Yeon Kim   +10 more
doaj   +1 more source

Neovascularization in Purtscher's retinopathy

open access: yes, 2011
Annie Chan, Douglas R Fredrick, Theodore Leng Department of Ophthalmology, Byers Eye Institute at Stanford University, Stanford University School of Medicine, Stanford, CA, USA Abstract: We report a case of neovascularization secondary to Purtscher& ...
Leng T, Chan A, Fredrick DR
core  

Atomically precise metal cluster enzymes for pathological tissue regeneration

open access: yesBMEMat, EarlyView.
Schematic illustration of atomically precise metal cluster enzymes (MCEs) for pathological tissue regeneration. Atomically precise MCEs can modulate biological processes, such as attenuation of inflammatory responses, eradication of bacterial pathogens, regulation of angiogenesis, and promotion of cell development.
Ziqiang Xiong   +11 more
wiley   +1 more source

Bevacizumab for the Treatment of Corneal Neovascularization

open access: yes, 2011
Corneal neovascularization (NV) is a severe complication associated with inflammatory or infectious disorders of the cornea. NV may lead to severe reduction in visual acuity and poor prognosis for corneal transplantation and excimer laser refractive ...
CHEN, WEI-LI;CHEN, YAN-MING;CHU, HSIAO-SANG;TSAI, TZU-YUN;HU, FUNG-RONG   +1 more
core  

Advanced nanotherapeutics for combating ocular infections: Rational design, antimicrobial mechanisms, and therapeutic breakthroughs

open access: yesBMEMat, EarlyView.
Nanomaterials revolutionize ocular infection treatment by enabling targeted drug delivery and enhanced antimicrobial efficacy against resistant pathogens. This review systematically explores their rational design, multimodal mechanisms, and translational potential for next‐generation anti‐infective therapies.
Yujia Liu   +7 more
wiley   +1 more source

Choroidal neovascularization secondary to Best’s vitelliform macular dystrophy in two siblings of a Malay family

open access: yes, 2014
Koh Alisa-Victoria,1 Tan Jin-Poi,1 Ismail Shatriah,1 Embong Zunaina,1 Nor Fariza Ngah2 1Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, 2Department of Ophthalmology, Hospital Selayang ...
Zunaina E   +3 more
core  

Transfersomes with core and surface‐loaded NF‐κB p65 siRNA for enhanced transdermal transfection and effective treatment of psoriasis

open access: yesBMEMat, EarlyView.
TCPL, a transfersome with Tween 80 and PEI, enables efficient transdermal siNF‐κB delivery, resolving PEI's toxicity issue. It promotes lysosomal escape and effective transfection, silences NF‐κB, modulates immunity, and inhibits angiogenesis, alleviating psoriasis. With good biocompatibility, TCPL holds strong clinical translation potential. Schematic
Hui Xing   +6 more
wiley   +1 more source

Fotocoagulación panretinal y bevacizumab intravítreo en el tratamiento de la retinopatía diabética proliferativa activa

open access: yesRevista Cubana de Oftalmología
Objetivo: evaluar el efecto de la fotocoagulación panretinal e inyección intravítrea de bevacizumab sobre las áreas de neovascularización en pacientes con retinopatía diabética proliferativa activa.
Arianna Hernández Pérez   +1 more
doaj  

Intravitreal Bevacizumab for Extrafoveal Choroidal Neovascularization Associated With Pathologic Myopia: 24-Month Outcomes

open access: yes, 2010
Purpose To evaluate the long-term efficacy and safety of intravitreal bevacizumab injection (IVBI) for the treatment of extrafoveal choroidal neovascularization (CNV) secondary to pathologic myopia.
P. Iacono   +7 more
core  

Home - About - Disclaimer - Privacy